Osteoporosis with vertebral fractures in young males, due to bone marrow mastocytosis: A report of two cases

Clinical and Experimental Rheumatology

Volumn 28, Issue 1, 2010, Pages 97-100

  Manara, Maria ^a   Varenna, M ^a   Cantoni, S ^b   Parafioriti, A ^a   Gallazzi, M B ^a   Sinigaglia, L ^a  

^a ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Male osteoporosis; Mastocytosis; Vertebral fractures

Indexed keywords

25 HYDROXYVITAMIN D; ALENDRONIC ACID; CALCIUM; TRYPTASE;

ADULT; ARTICLE; BONE BIOPSY; BONE DENSITOMETRY; BONE DENSITY; BONE MARROW; BONE MARROW BIOPSY; CASE REPORT; CELL STRUCTURE; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; FRAGILITY FRACTURE; HUMAN; HUMAN CELL; LOW BACK PAIN; LUMBAR SPINE; LUMBAR VERTEBRA; MALE; MAST CELL; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; SPINE RADIOGRAPHY; SYSTEMIC MASTOCYTOSIS; VERTEBRA FRACTURE; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADULT; BIOPSY; BONE MARROW; HUMANS; MALE; MAST CELLS; MASTOCYTOSIS; OSTEOPOROSIS; SPINAL FRACTURES;

EID: 77949509217     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. HORNY HP, SOTLAR K, VALENT P: Mastocytosis: state of the art. Pathobiology 2007; 74: 121-32.
2. PATNAIK MM, RINDOS M, KOUIDES PA et al.: Systemic mastocytosis: a concise clinical and laboratory review. Arch Pathol Lab Med 2007; 131: 784-91.
3. CACACE E, SALIS G, RUGGIERO V et al.: Systemic mast cell disease: a rare cause of osteoporosis. Clin Exp Rheumatol 2006; 24: 210.
4. MCKENNA MJ, FRAME B: The mast cell and bone. Clin Orthop Relat Res 1985; 200: 226-33.
5. BRUMSEN C, PAPAPOULOS SE, LENTJES EG et al.: A potential role for the mast cell in the pathogenesis of idiopathic osteoporosis in men. Bone 2002; 31: 556-61.
6. KING JJ, CRAWFORD EA, IWENOFU OH, FOX EJ: Case report: pathologic long bone fracture in a patient with systemic mastocytosis. Clin Orthop Relat Res 2007; 459: 263-9.
7. DELLING G, RITZEL H, WERNER M: Histological characteristic and prevalence of secondary osteoporosis in systemic mastocytosis. A retrospective analysis of 158 cases. Pathologe 2001; 22: 132-40.
8. GRIESER T, MINNE HW: Systemic mastocytosis and skeletal lesions. Lancet 1997; 350: 1103-4.
9. URIST MR, MCLEAN FC: Accumulation of mast cells in endosteum of bones of calcium-deficient rats. AMA Arch Pathol 1957; 63: 239-51.
10. FRAME B, NIXON RK: Bone marrow mast cells in osteoporosis of aging. N Engl J Med 1968; 279: 626-30.
11. FRAME B, NIXON RK: Bone marrow factors in osteoporosis. In: Barzel US: Osteoporoses 1970.
12. PEART KM, ELLIS HA: Quantitative obser vation on iliac bone marrow mast cells in chronic renal failure. J Clin Pathol 1975; 28: 947-55.
13. FALLON MD, WHYTE MP, CRAIG RB JR et al.: Mast-cell proliferation in postmenopausal osteoporosis. Calcif Tissue Int 1983; 35: 29-31.
14. CHIAPPETTA N, GRUBER B: The role of mast cells in osteoporosis. Semin Arthritis Rheum 2006; 36: 32-6.
15. AVIOLI LV: Heparin-induced osteopenia: an appraisal. Adv Exp Med Biol 1975; 52: 375-87.
16. THEOHARIDES TC, BOUCHER W, SPEAR K: Serum interleukin-6 reflects disease severity and osteoporosis in mastocytosis patients. Int Arch Allergy Immunol 2002; 128: 344-50.
17. TEFFERI A, VERSTOVSEK S, PARDANANI A: How we diagnose and treat WHO-defined systemic mastocytosis in adults. Haematologica 2008; 93: 6-9.
18. LIM AY, OSTOR AJ, LOVE S et al.: Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment. Ann Rheum Dis 2005; 64: 965-6.
19. MARSHALL A, KAVANAGH RT, CRISP AJ: The effect of pamidronate on lumbar spine bone density and pain in osteoporosis secondary to systemic mastocytosis. Br J Rheumatol 1997; 36: 393-6.
20. LAROCHE M, BRET J, BROUCHET A et al.: Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis. Clin Rheumatol 2007; 26: 242-3.
21. BRUMSEN C, HAMDY NA, PAPAPOULOS SE: Osteoporosis and bone marrow mastocytosis: dissociation of skeletal responses and mast cell activity during long-term bisphosphonate therapy. J Bone Miner Res 2002; 17: 567-9.
22. PERIS P, MARTINEZ-FERRER A, MONEGAL A et al.: Aetiology and clinical characteristics of male osteoporosis. Have they changed in the last few years? Clin Exp Rheumatol 2008; 26: 582-8
23. SCHWARTZ LB, METCALFE DD, MILLER JS et al.: Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987; 316: 1622-6.